1887

Abstract

Survivin has recently been identified as a novel member of the inhibitor of apoptosis (IAP) gene family. The product of this gene not only suppresses apoptosis but also controls cell division. Survivin is undetectable in most terminally differentiated normal tissues but is expressed in embryonic and fetal organs and is present in most malignant tumours. Human papillomaviruses (HPV) are thought to play an important role in the development of cervical cancer. By interfering in the cell cycle, the viral oncoproteins (E6 and E7) can induce the immortalization of the host cell. The transcriptional effects of the HPV-16 E6 and E7 proteins on the survivin promoter in transiently transfected cell lines using luciferase tests were examined. HPV-16 E6, but not E7, was found to significantly transactivate the survivin promoter. Experiments performed in different cancer cell lines and with different E6 mutants indicated that the effect of E6 on the survivin promoter is largely dependent on p53 status. In accordance with this, the p53 tumour suppressor protein downregulated the expression of survivin. As E6 is able to interact with p53 and induces its ubiquitin-dependent degradation, it appears that the transactivation effect of E6 on survivin is mediated by the p53 degradation pathway. Transduction of HPV-16 E6 and E7 into human embryonic fibroblast cells showed that the HPV oncoproteins can upregulate endogenous survivin mRNA. Importantly, cell cycle synchronization experiments showed that the effect of HPV-16 E6 on survivin transcription is independent of the cell cycle.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81067-0
2006-02-01
2019-11-12
Loading full text...

Full text loading...

/deliver/fulltext/jgv/87/2/287.html?itemId=/content/journal/jgv/10.1099/vir.0.81067-0&mimeType=html&fmt=ahah

References

  1. Aguilar-Lemarroy, A., Gariglio, P., Whitaker, N. J., Eichhorst, S. T., zur Hausen, H., Krammer, P. H. & Rosl, F. ( 2002; ). Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene 21, 165–175.[CrossRef]
    [Google Scholar]
  2. Alfandari, J., Shnitman Magal, S., Jackman, A., Schlegel, R., Gonen, P. & Sherman, L. ( 1999; ). HPV16 E6 oncoprotein inhibits apoptosis induced during serum-calcium differentiation of foreskin human keratinocytes. Virology 257, 383–396.[CrossRef]
    [Google Scholar]
  3. Altieri, D. C. ( 2001; ). The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7, 542–547.[CrossRef]
    [Google Scholar]
  4. Ambrosini, G., Adida, C. & Altieri, D. C. ( 1997; ). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3, 917–921.[CrossRef]
    [Google Scholar]
  5. Crook, T., Tidy, J. A. & Vousden, K. H. ( 1991; ). Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67, 547–556.[CrossRef]
    [Google Scholar]
  6. Cuconati, A. & White, E. ( 2002; ). Viral homologs of BCL-2: role of apoptosis in the regulation of virus infection. Genes Dev 16, 2465–2478.[CrossRef]
    [Google Scholar]
  7. Davies, R., Hicks, R., Crook, T., Morris, J. & Vousden, K. ( 1993; ). Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J Virol 67, 2521–2528.
    [Google Scholar]
  8. Desaintes, C., Hallez, S., Van Alphen, P. & Burny, A. ( 1992; ). Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J Virol 66, 325–333.
    [Google Scholar]
  9. Deveraux, Q. L. & Reed, J. C. ( 1999; ). IAP family proteins – suppressors of apoptosis. Genes Dev 13, 239–252.[CrossRef]
    [Google Scholar]
  10. Finzer, P., Aguilar-Lemarroy, A. & Rosl, F. ( 2002; ). The role of human papillomavirus oncoproteins E6 and E7 in apoptosis. Cancer Lett 188, 15–24.[CrossRef]
    [Google Scholar]
  11. Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E. & Shay, J. W. ( 1992; ). A transcriptionally active DNA-binding site for human p53 protein complexes. Mol Cell Biol 12, 2866–2871.
    [Google Scholar]
  12. Halbert, C. L., Demers, G. W. & Galloway, D. A. ( 1991; ). The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol 65, 473–478.
    [Google Scholar]
  13. Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J. & Murphy, M. ( 2002; ). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277, 3247–3257.[CrossRef]
    [Google Scholar]
  14. Kim, H. S., Shiraki, K. & Park, S. H. ( 2002; ). Expression of survivin in CIN and invasive squamous cell carcinoma of uterine cervix. Anticancer Res 22, 805–808.
    [Google Scholar]
  15. Klingelhutz, A. J., Foster, S. A. & McDougall, J. K. ( 1996; ). Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380, 79–82.[CrossRef]
    [Google Scholar]
  16. Li, F. ( 2005; ). Role of survivin and its splice variants in tumorigenesis. Br J Cancer 92, 212–216.
    [Google Scholar]
  17. Li, F. & Altieri, D. C. ( 1999; ). Transcriptional analysis of human survivin gene expression. Biochem J 344, 305–311.[CrossRef]
    [Google Scholar]
  18. Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C. & Altieri, D. C. ( 1998; ). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, 580–584.[CrossRef]
    [Google Scholar]
  19. Löhr, K., Moritz, C., Contente, A. & Dobbelstein, M. ( 2003; ). p21/CDKN1A mediates negative regulation of transcription by p53. J Biol Chem 278, 32507–32516.[CrossRef]
    [Google Scholar]
  20. Lopez-Ocejo, O., Viloria-Petit, A., Bequet-Romero, M., Mukhopadhyay, D., Rak, J. & Kerbel, R. S. ( 2000; ). Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 19, 4611–4620.[CrossRef]
    [Google Scholar]
  21. Mirza, A., McGuirk, M., Hockenberry, T. N. & 10 other authors ( 2002; ). Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene 21, 2613–2622.[CrossRef]
    [Google Scholar]
  22. Münger, K. & Howley, P. M. ( 2002; ). Human papillomavirus immortalization and transformation functions. Virus Res 89, 213–228.[CrossRef]
    [Google Scholar]
  23. Münger, K., Basile, J. R., Duensing, S., Eichten, A., Gonzalez, S. L., Grace, M. & Zacny, V. L. ( 2001; ). Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888–7898.[CrossRef]
    [Google Scholar]
  24. Murvai, M., Borbély, A. A., Kónya, J., Gergely, L. & Veress, G. ( 2004; ). Effect of human papillomavirus type 16 E6 and E7 oncogenes on the activity of the transforming growth factor-β2 (TGF-β2) promoter. Arch Virol 149, 2379–2392.[CrossRef]
    [Google Scholar]
  25. Nees, M., Geoghegan, J. M., Munson, P., Prabhu, V., Liu, Y., Androphy, E. & Woodworth, C. D. ( 2000; ). Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-β2 in cervical keratinocytes. Cancer Res 60, 4289–4298.
    [Google Scholar]
  26. Punga, T. & Akusjarvi, G. ( 2003; ). Adenovirus 2 E1B-55K protein relieves p53-mediated transcriptional repression of the survivin and MAP4 promoters. FEBS Lett 552, 214–218.[CrossRef]
    [Google Scholar]
  27. Rapp, L. & Chen, J. J. ( 1998; ). The papillomavirus E6 proteins. Biochim Biophys Acta 1378, 1–19.
    [Google Scholar]
  28. Saitoh, Y., Yaginuma, Y. & Ishikawa, M. ( 1999; ). Analysis of Bcl-2, Bax and Survivin genes in uterine cancer. Int J Oncol 15, 137–141.
    [Google Scholar]
  29. Sommer, K. W., Schamberger, C. J., Schmidt, G. E., Sasgary, S. & Cerni, C. ( 2003; ). Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 22, 4266–4280.[CrossRef]
    [Google Scholar]
  30. Thomas, M., Kalita, A., Labrecque, S., Pim, D., Banks, L. & Matlashewski, G. ( 1999; ). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19, 1092–1100.
    [Google Scholar]
  31. Zhu, Y., Roshal, M., Li, F., Blackett, J. & Planelles, V. ( 2003; ). Upregulation of survivin by HIV-1 Vpr. Apoptosis 8, 71–79.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81067-0
Loading
/content/journal/jgv/10.1099/vir.0.81067-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error